AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析

◆英語タイトル:AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1662
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:77
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥17,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

AbbVie Inc (ABBV) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AbbVie Inc (AbbVie) is a specialty biopharmaceutical company that discovers, develops, manufactures and commercializes drugs for the treatment of chronic and complex diseases. Its pharmaceuticals are indicated to treat metabolic diseases, rheumatological diseases, neurological disorders, viral diseases, skin diseases, complications associated with cystic fibrosis, pain related to endometriosis, diseases of the gastrointestinal tract, various cancer types, and other serious health conditions. AbbVie is also advancing its pipeline programs for the treatment of cystic fibrosis, Women’s Health, various cancers, neurological disorders and other autoimmune diseases. The company markets its products directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its own distribution centers and public warehouses across the world. AbbVie is headquartered in North Chicago, Illinois, the US.

AbbVie Inc Key Recent Developments

Apr 27,2020 AbbVie announces extension of expiration date for exchange offers for Allergan notes
Mar 10,2020 2019 Full-Year Results: Significant progress in NASH, MPS VI and psoriasis, and extended cash runway
Feb 28,2020 FinnGen grows to one of the largest private-public studies in the world
Feb 24,2020 AbbVie announces extension of expiration date for exchange offers for Allergan notes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
AbbVie Inc – Key Facts
AbbVie Inc – Key Employees
AbbVie Inc – Key Employee Biographies
AbbVie Inc – Major Products and Services
AbbVie Inc – History
AbbVie Inc – Company Statement
AbbVie Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AbbVie Inc – Business Description
Product Category: All Other
Performance
Product Category: AndroGel
Performance
Product Category: Creon
Performance
Product Category: Duodopa
Performance
Product Category: HUMIRA
Performance
Product Category: IMBRUVICA
Performance
Product Category: Kaletra
Performance
Product Category: Lupron
Performance
Product Category: MAVYRET
Performance
Product Category: ORILISSA
Performance
Product Category: RINVOQ
Performance
Product Category: Sevoflurane
Performance
Product Category: SKYRIZI
Performance
Product Category: Synagis
Performance
Product Category: Synthroid
Performance
Product Category: VENCLEXTA
Performance
Product Category: VIEKIRA
Performance
Product Category: Pharmaceuticals
Overview
Performance
Geographical Segment: All Other Countries
Performance
Geographical Segment: Brazil
Performance
Geographical Segment: Canada
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Italy
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Spain
Performance
Geographical Segment: The Netherlands
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
R&D Overview
AbbVie Inc – Corporate Strategy
AbbVie Inc – SWOT Analysis
SWOT Analysis – Overview
AbbVie Inc – Strengths
AbbVie Inc – Weaknesses
AbbVie Inc – Opportunities
AbbVie Inc – Threats
AbbVie Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AbbVie Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 27, 2020: AbbVie announces extension of expiration date for exchange offers for Allergan notes
Mar 10, 2020: 2019 Full-Year Results: Significant progress in NASH, MPS VI and psoriasis, and extended cash runway
Feb 28, 2020: FinnGen grows to one of the largest private-public studies in the world
Feb 24, 2020: AbbVie announces extension of expiration date for exchange offers for Allergan notes
Feb 21, 2020: Covid-19: First coronavirus vaccine trial submission expected in April
Feb 13, 2020: Results from Covid-19-focused trials in China may come within weeks
Feb 07, 2020: AbbVie reports full-year and fourth-quarter 2019 financial results
Jan 27, 2020: AbbVie and Allergan to sell brazikumab and Zenpep
Jan 27, 2020: Coronavirus: China tests AbbVie’s HIV drugs; Sirnaomics explores RNAi candidates
Jan 08, 2020: AbbVie announces leadership team and creation of new business, Allergan Aesthetics, upon completion of acquisition
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
AbbVie Inc, Key Facts
AbbVie Inc, Key Employees
AbbVie Inc, Key Employee Biographies
AbbVie Inc, Major Products and Services
AbbVie Inc, History
AbbVie Inc, Subsidiaries
AbbVie Inc, Key Competitors
AbbVie Inc, Ratios based on current share price
AbbVie Inc, Annual Ratios
AbbVie Inc, Annual Ratios (Cont...1)
AbbVie Inc, Annual Ratios (Cont...2)
AbbVie Inc, Interim Ratios
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AbbVie Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
AbbVie Inc, Performance Chart (2015 - 2019)
AbbVie Inc, Ratio Charts
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AbbVie Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Financial and Strategic SWOT Analysis Review
    Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportuni …
  • Premaitha Health Plc (NIPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • Huneed Technologies:企業の戦略・SWOT・財務情報
    Huneed Technologies - Strategy, SWOT and Corporate Finance Report Summary Huneed Technologies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Neste Corporation (NESTE):石油・ガス:M&Aディール及び事業提携情報
    Summary Neste Corp (Neste) is an oil refining and marketing company that offers advanced, clean traffic fuels besides shipping and engineering services. The company produces and sells gasoline; diesel fuel; aviation fuel; bunker fuel; heating oil; light and heavy fuel oil; base oils; gasoline compon …
  • Infineon Technologies AG:企業の戦略・SWOT・財務情報
    Infineon Technologies AG - Strategy, SWOT and Corporate Finance Report Summary Infineon Technologies AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Comision Federal de Electricidad-エネルギー分野:企業M&A・提携分析
    Summary Comision Federal de Electricidad (CFE) is a Mexican state owned power utility. It carries out the generation, transmission, distribution, supply and commercialization of electricity. The company generates electricity through various energy sources including thermal, hydro, coal-fired, wind, …
  • Belfius Bank SA:企業の戦略・SWOT・財務情報
    Belfius Bank SA - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SolarWinds North America Inc:企業の戦略的SWOT分析
    SolarWinds North America Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Saskatchewan Telecommunications Holding Corporation:企業の戦略的SWOT分析
    Saskatchewan Telecommunications Holding Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …
  • QEP Resources, Inc.:企業の戦略・SWOT・財務分析
    QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Scripps Networks Interactive, Inc.:企業のM&A・事業提携・投資動向
    Scripps Networks Interactive, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Scripps Networks Interactive, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Otonomy Inc (OTIC):企業の財務・戦略的SWOT分析
    Otonomy Inc (OTIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • AU Optronics Corp.:企業の戦略・SWOT・財務分析
    AU Optronics Corp. - Strategy, SWOT and Corporate Finance Report Summary AU Optronics Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ORBIT Communication Systems Ltd:企業の戦略・SWOT・財務情報
    ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Mitsubishi Motors Corporation (7211):企業の財務・戦略的SWOT分析
    Mitsubishi Motors Corporation (7211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Kuwait Petroleum International Ltd:企業の戦略的SWOT分析
    Kuwait Petroleum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Sabah Electricity Sdn Bhd:企業の戦略的SWOT分析
    Sabah Electricity Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • NovaMedica LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NovaMedica LLC (NovaMedica) is a pharmaceutical company that develops drugs for various therapeutic areas. The company offers drugs in the areas of cardiovascular, central nervous system, dermatology, endocrinology, gynecology, infectious disease, gastrointestinal, pediatric, woman’s health, …
  • University of California Los Angeles:医療機器:M&Aディール及び事業提携情報
    Summary University of California Los Angeles (UCLA) a subsidiary of University of California, is an educational service provider that offers undergraduate education, graduate, professional education and continuing education. The university’s services include support services, campus services, gradua …
  • Marco’s Franchising, LLC:企業の戦略・SWOT・財務情報
    Marco's Franchising, LLC - Strategy, SWOT and Corporate Finance Report Summary Marco's Franchising, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆